Skip to content

Clinical trials

Phase 1/2 Head and Neck Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 1/2 Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20174
20192
20201
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CytomX Therapeutics1
Eli Lilly and Company1
Erasmus Medical Center1
Genmab1
Hoffmann-La Roche1
Hookipa Biotech GmbH1
Maastricht University Medical Center1
Merus B.V.1
Radboud University Medical Center1
The Netherlands Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms11
Neoplasms4
Carcinoma3
Carcinoma, Non-Small-Cell Lung3
Neoplasms by Site3
Ovarian Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Adenocarcinoma2
Breast Neoplasms2
Bronchial Neoplasms2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.